Back to Companies
Camp4 Therapeutics Corp
CAMPNasdaqCIK: 0001736730
Recent Form 4 activity at Camp4 Therapeutics Corp (CAMP) spans 24 filings across 13 insiders (all of them on the buy side). Purchases total $8.6M against $0 in sales — heavily weighted toward buying, for a net purchase of $8.6M. Mandel-Brehm Josh (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $4.5M by Schwab Andrew J.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$24.9M
Purchases
$8.6M
Sales
$0
Unique Insiders
13
Recent Insider Trades
24 loaded
| Jun 12 | CAMP Camp4 Therapeutics Corp | Holtzman Steven H | Director | Award | $121.5K |
| Jun 12 | CAMP Camp4 Therapeutics Corp | Young Richard A | Director | Award | $121.5K |
| Jun 12 | CAMP Camp4 Therapeutics Corp | Schwab Andrew J. | Director, 10% Owner | Award | $121.5K |
| Jun 12 | CAMP Camp4 Therapeutics Corp | WILLIAMS DOUGLAS E | Director | Award | $121.5K |
| Jun 12 | CAMP Camp4 Therapeutics Corp | Stewart Murray | Director | Award | $121.5K |
| Apr 3 | CAMP Camp4 Therapeutics Corp | MacLean Michael F | Director | Other | $0 |
| Apr 3 | CAMP Camp4 Therapeutics Corp | Tardiff Daniel | Chief Scientific Officer | Award | $758.2K |
| Apr 3 | CAMP Camp4 Therapeutics Corp | Gold Kelly | Chief Financial Officer | Award | $958.9K |
| Apr 3 | CAMP Camp4 Therapeutics Corp | Mandel-Brehm Josh | Chief Executive Officer, Director | Award | $2.6M |
| Apr 3 | CAMP Camp4 Therapeutics Corp | Maricich Yuri | Chief Medical Officer | Award | $958.9K |
| Apr 3 | CAMP Camp4 Therapeutics Corp | MacLean Michael F | Director | Award | $249.8K |
| Dec 22 | CAMP Camp4 Therapeutics Corp | Maricich Yuri | Chief Medical Officer | Award | $1.1M |
| Dec 22 | CAMP Camp4 Therapeutics Corp | Gold Kelly | Chief Financial Officer | Award | $1.1M |
| Dec 22 | CAMP Camp4 Therapeutics Corp | Mandel-Brehm Josh | Chief Executive Officer, Director | Award | $2.6M |
| Dec 22 | CAMP Camp4 Therapeutics Corp | Tardiff Daniel | Chief Scientific Officer | Award | $874.5K |
| Oct 10 | CAMP Camp4 Therapeutics Corp | Tardiff Daniel | Chief Scientific Officer | Other | $0 |
| Sep 11 | CAMP Camp4 Therapeutics Corp | Mandel-Brehm Josh | Chief Executive Officer, Director | Buy | $10.0K |
| Sep 11 | CAMP Camp4 Therapeutics Corp | Nashat Amir | Insider | Buy | $2.0M |
| Sep 11 | CAMP Camp4 Therapeutics Corp | Polaris Management Co. VII, L.L.C. | Insider | Buy | $2.0M |
| Sep 15 | CAMP Camp4 Therapeutics Corp | Schwab Andrew J. | Insider | Grant | $4.5M |
| Sep 11 | CAMP Camp4 Therapeutics Corp | Maricich Yuri | Chief Medical Officer | Buy | $10.0K |
| Sep 11 | CAMP Camp4 Therapeutics Corp | Young Richard A | Director | Buy | $25.0K |
| Sep 15 | CAMP Camp4 Therapeutics Corp | 5AM Partners VI, LLC | Insider | Buy | $4.5M |
| Sep 11 | CAMP Camp4 Therapeutics Corp | Gold Kelly | Chief Financial Officer | Buy | $10.0K |
24 filings